Human B7-1/CD80 Antibody, R&D Systems™

B7-1/CD80

LYOPH

Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF, In Situ Hybridization (ISH), ELISA

Unconjugated

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

Activation B7-1 antigen, B7, B71, BB1, CD28LG1, CD28LGB7-1 antigen), CD80, CD80 antigen, CD80 molecule, costimulatory factor CD80, costimulatory molecule variant IgV-CD80, CTLA-4 counter-receptor B7.1, T-lymphocyte activation antigen CD80

CD80

IgG1

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

37711

Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 5-25 ug/mL, Neutralization 0.2-1 ug/mL, CyTOF-ready, Dual RNAscope ISH-IHC 5-25 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

Monoclonal

Mouse

Human

P33681

941

S. frugiperdainsect ovarian cell lineSf21-derived recombinant human B7-1/CD80 Val35-Asn242 (predicted) Accession # P33681

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human B7-1/CD80 in ELISAs. In sandwich immunoassays, no cross-reactivity or interference with recombinant human (rh) B7-2, recombinant mouse (rm) B7-1, rmB7-2, rhB7-H1, rhB7-H2, rhB7-H3 or rmPD-L2 is observed.